Aug 10, 2026 09:10AM

Aug 5, 2026 04:05PM

Jun 2, 2026 12:32PM

May 5, 2026 04:05PM

Feb 25, 2026 04:05PM

Nov 5, 2025 04:05PM

Aug 6, 2025 04:05PM Schrödinger Reports Second Quarter 2025 Financial Results

May 7, 2025 04:05PM

Feb 26, 2025 04:05PM

Nov 12, 2024 06:50AM

Jul 31, 2024 04:05PM

May 1, 2024 04:00PM

Feb 28, 2024 04:05PM

Nov 1, 2023 04:00PM Schrödinger Reports Third Quarter 2023 Financial Results

Sep 28, 2023 08:00AM

Aug 2, 2023 04:00PM

May 4, 2023 04:00PM

Feb 28, 2023 04:00PM

Feb 14, 2023 07:14AM

Feb 14, 2023 07:00AM

Jan 9, 2023 07:00AM Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities

Nov 3, 2022 04:00PM

Aug 18, 2022 07:01AM

Aug 18, 2022 07:01AM

Aug 4, 2022 04:00PM

May 4, 2022 04:01PM

Feb 24, 2022 04:01PM

Jan 24, 2022 09:27AM Schrodinger (SDGR) Management Meetings Demonstrate Confidence in Drug Discovery Business - Piper Sandler

Jan 18, 2022 06:46AM

Jan 18, 2022 06:45AM

Aug 12, 2021 07:01AM

Apr 28, 2021 06:23AM

Mar 4, 2021 09:27AM

Aug 11, 2020 09:30AM

Jul 19, 2020 08:00PM Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Jul 19, 2020 07:05PM

Feb 21, 2020 09:12AM

1,179,924 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All